Key result
MitraClip repair is linked to fatal infective endocarditis at one month in an ESRD patient.
Why the study?
Infective endocarditis is a known but unusual complication following transcutaneous mitral valve repair, with limited data in hemodialysis patients.
Case Report (n=1)
Highlights infective endocarditis as a potential early complication following transcutaneous mitral valve repair in hemodialysis patients.
Transcutaneous mitral valve repair is an interventional procedure increasingly used as a method of treatment for patients with symptomatic mitral regurgitation deemed to be poor surgical candidates.The procedure involves clipping the mitral valve leaflets at the point of maximal regurgitation.This procedure has been shown to be well tolerated with an acceptable risk profile.Infective endocarditis is a known but unusual complication of this procedure.We describe a case of infective endocarditis following implantation of a MitraClip (Abbott Laboratories) in a hemodialysis patient.
No takes yet. Share an insight, caveat, or question.
Vp et al. (2018) conducted a case report in Infective endocarditis following MitraClip placement (n=1). MitraClip was evaluated on Development of infective endocarditis. A 76-year-old female with end-stage renal disease on hemodialysis developed fatal infective endocarditis one month after undergoing transcatheter mitral valve repair with a MitraClip.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: